Academic Journal
Προβολή σε EDS

Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies
Συγγραφείς: Burmester, Gerd R.Aff1, IDs4074402600874x_cor1, Galloway, JamesAff2, Bevers, KarenAff3, Avouac, JérômeAff4, Romero-Yuste, SusanaAff5, Caporali, Roberto F.Aff6, Aff7, Betteridge, NeilAff8, Van der Donckt, CaroleAff9, Debray, Thomas P. A.Aff10, Tandjaoui Bouzid, OuafiaAff9, Verschueren, PatrickAff11
Πηγή: Rheumatology and Therapy. 13(5):1287-1308
Βάση Δεδομένων: Springer Nature Journals
Περιγραφή
ISSN:21986576
21986584
DOI:10.1007/s40744-026-00874-x